Official AMFI data
Arthkar — Understand Money, Invest Smartly

Listed equity

India Glycols

इंडिया ग्लायकोल · ઇન્ડિયા ગ્લ્ય્કોસ

NSE: INDIAGLYCOBSE: 500201M-cap ₹7.5K Cr2 mutual funds hold this
1097.6035.25(-3.07%)

EOD close · 1 Sept 2026

consolidationneutral -3

Range-bound — awaiting direction.

52W low ₹793.9552W high ₹1222.85

Now at 71% of its 52-week range

Last 30 sessions

-4.5%

Phase indicator

consolidation-10.2% from 52w high

Range-bound — awaiting direction.

1M
-2.9%
3M
+11.9%
1Y
+36.9%

Delivery conviction

neutralscore -3
Delivery vs 20-day avg1.18x
Buy / sell pressure47.2% buy

Lifetime story

India Glycols is up 12812.9% from its lifetime low of 8.50 on 11 May 2000. ₹10,000 invested then would be worth 12,91,294 today (20.3% CAGR over 26.3 years). Lifetime high of 1222.85 was set on 20 Nov 2025 (currently -10.2% below).

30-day conviction trend

21 Jul 20261 Sept 2026

Fundamentals

Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.

61% cheaper than industry(Industry P/E 62.9)
StandaloneConsolidated
P/E (TTM)24.3723.58
P/B2.862.48
Price / Cash flow16.1615.81
Dividend yield0.67%0.67%
Book value / share390.00 ₹448.93 ₹
EPS (TTM)45.66 ₹47.20 ₹
Market cap
₹7.5K Cr
52W high
₹1222.85
20 Nov 2025
52W low
₹793.95
27 Jan 2026

Returns ladder

1W
-4.8%
1M
-2.9%
3M
+11.9%
6M
+15.8%
YTD
+9.2%
1Y
+36.9%
3Y
+189.4%
5Y
+216.7%
10Y
+1991.9%
Since listing
+6604.2%

How this page is produced

Every figure above is computed from end-of-day exchange prices, snapshotted daily, closing 1 Sept 2026. Nothing here is copied from a factsheet or a third-party summary. The full method is published, including its limitations.

Prices are end-of-day closes, not live quotes, and are not intended for trading decisions.

Written and maintained by Azad Mohammed, who built the pipeline these numbers come out of. Found an error? Tell us — corrections are made and the page rebuilds within the hour.

This page describes what has already happened. It is not investment advice and not a recommendation to buy or sell any security. Arthkar is not a SEBI-registered investment adviser or research analyst, and does not provide or arrange investment advice. Investments in securities are subject to market risk.